1. Home
  2. PL vs LQDA Comparison

PL vs LQDA Comparison

Compare PL & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$13.10

Market Cap

6.3B

Sector

Industrials

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$39.45

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
LQDA
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.5B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
PL
LQDA
Price
$13.10
$39.45
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
$30.27
★ $54.38
AVG Volume (30 Days)
★ 8.6M
4.7M
Earning Date
12-09-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 51.81
EPS
N/A
★ 1.26
Revenue
★ $307,727,000.00
$158,320,000.00
Revenue This Year
$42.22
$357.27
Revenue Next Year
$30.36
$1.34
P/E Ratio
★ N/A
$30.82
Revenue Growth
25.94
★ 1031.18
52 Week Low
$10.52
$22.05
52 Week High
$51.72
$93.61

Technical Indicators

Market Signals
Indicator
PL
LQDA
Relative Strength Index (RSI) 29.66 43.19
Support Level N/A $35.00
Resistance Level $18.49 $40.60
Average True Range (ATR) 0.78 2.80
MACD -0.20 1.92
Stochastic Oscillator 2.44 96.06

Price Performance

Historical Comparison
PL
LQDA

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: